Schedule:

 

…        Children

2 doses:Ý First at 12-15 months (NOT before 12 months)

ÝÝÝÝÝ ÝÝÝÝÝÝÝÝ Second can be received at any age, as long as at least 28 days have passed

since first dose.Ý Recommended age is 4-6 years

…        Adults 18 and up, born after 1956, who do not have record of MMR vaccination or disease, should get at least 1 dose of MMR

** Other vaccines may be given at the same time as MMR

 

Contraindications:

 

…        Severe allergic reaction to gelatin, neomycin or a previous dose of MMR

…        ModerateÝ to severe illness at time vaccination is scheduled

…        Pregnancy, or likelihood of pregnancy within next 3 months

 

Conditions for which one should talk to a doctor before vaccination:

 

…        HIV infection or other immunosuppression

…        Taking drugs that suppress the immune system (like steroids) for 2 weeks or longer

…        Cancer

…        Receiving cancer treatment, including radiation and chemotherapy

…        Low platelet count

…        Recent recipient of a blood transfusion

 

Risks:Ý

 

…        Mild ñ usually occur 7-12 days after vaccination

Fever (1 in 6)

Mild rash (1 in 20)

Swelling of glands in neck and cheek areas (rare)

…        Moderate

Fever induced seizures (1 in 3000)

Temporary pain and stiffness in joints (1 in 4 teenage or adult women)

Temporary low platelet count (1 in 30,000)

…        Severe ñ All except allergic reaction are so rare that it has been impossible to

determine that they are actually caused by the vaccine:

ÝÝÝÝÝÝÝÝÝÝÝ Allergic Reaction (1 in 1 million)

ÝÝÝÝÝÝÝÝÝÝÝ Deafness

ÝÝÝÝÝÝÝÝÝÝÝ Long term seizures

ÝÝÝÝÝÝÝÝÝÝÝ Coma

ÝÝÝÝÝÝÝÝÝÝÝ Brain Damage

** Getting MMR vaccine is much safer than getting any of the diseases against which it protects

 

Coverage:

 

…        National vaccination coverage for one or more doses of a Measles Containing Vaccine (MCV)ß among children 19-35 mos. (born 2/95-5/97), 1995-1998 (National Immunization Survey):

 

YearÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ % Vaccinated (95% Confidence Interval (CI))
1995ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 89.9 (± 0.7)

1996                                                                                                                                            90.7 (± 0.5)

1997                                                                                                                                            90.5 (± 0.5)

1998                                                                                                                                            92.1 (± 0.6)*

* In 1998, vaccine coverage for an MCV was higher than for any other vaccine in the survey

ÝÝÝÝÝÝ * 1998 vaccine coverage in Rhode Island for an MCV was 96.5% (± 2.2)

 

…        Estimated vaccine coverage with one or more doses of an MCV among children 19-35 mos. (born 2/95-5/97), by race/ethnicity, in U.S. (National Immunization Survey, 1998):

ÝÝÝÝÝÝÝÝÝÝ

ÝÝÝÝ Race/ EthnicityÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ % Vaccinated (95%CI)

White Non-HispanicÝÝ ÝÝÝÝÝÝÝÝÝÝÝÝÝ ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 93.3 (± 0.7)Ý ÝÝ

Black Non-HispanicÝÝ ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 88.9 (± 2.0)

Hispanic (of any race)ÝÝÝÝÝÝÝÝ ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 91.2 (± 1.6)

American Indian/Alaska NativeÝ ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 91.4 (± 7.0)

Asian/Pacific IslanderÝÝÝÝÝÝÝÝ ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 92.4 (± 3.3)

 

…        1998 Vaccine Coverage with one or more doses of an MCV among children 19-35 mos. living below the poverty level (National Immunization Survey):

 

RegionÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ % Vaccinated (95% CI)ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ Percent in Poverty

United StatesÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 90.2 (± 1.3)ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 21.6

New EnglandÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 91.6 (± 4.2)ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 15.6

Rhode IslandÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 91.1 (± 7.9)ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 20.0

 

The average annual number of measles cases in 1958-1962 (the 5

ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ years before vaccine licensure): 503,282. U.S. cases in 1998: 89.

ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ The number of mumps cases in 1968 (the year reporting began and

ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ the first year after licensure): 152,209. U.S. cases in 1998: 606.

ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ The average annual number of rubella cases in 1966-1968 (the 3

ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ years before vaccine licensure): 47,745. U.S. cases in 1998: 345.

ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ ÝÝÝThe estimated average annual number of cases of congenital rubella

ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ syndrome in 1966-1968 (the 3 years before vaccine licensure):

ÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝÝ 823. U.S. cases in 1998: 5.